Designing integrated early-phase protocols to reduce substantial modifications, including considerations for patient cohorts - a multi-stakeholder consensus view for a practical approach in Germany
设计整合式早期临床试验方案以减少重大修改，包括考虑患者群体——德国多方利益相关者就切实可行的方案达成共识
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1699906
Schultz-Heienbrok, R; Baumann, S; Böhm, R; Bonertz, A; Breithaupt-Groegler, K; Buckpesch-Heberer, U; Coenen, M; Erb-Zohar, K; Faisst, N; Grass, G; Höchel, J; Kovar, A; Muehlenbroich, A; Rengelshausen, J; Riedel, C; Schug, B; Sudhop, T; Warnke, A; Ziegele, B
